Sanofi Could Be on a Roll With a Strong Performance and Its Latest FDA Approval
6/3 13:05
French pharmaceutical company Sanofi (NASDAQ: SNY) is seeing a jump in its share price following major product news on Feb. 23. The company shared that the Food and Drug Administration (FDA) had approved Altuviiio for hemophilia A, an inherited blood clotting disorder. The new dr...